Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
J Electrocardiol ; 84: 1-8, 2024 Feb 28.
Artigo em Inglês | MEDLINE | ID: mdl-38430664

RESUMO

BACKGROUND: Accurate estimation of accessory pathway (AP) localization in patients with ventricular pre-excitation or Wolff-Parkinson-White (WPW) syndrome remains a diagnostic challenge. Existing algorithms have contributed significantly to this area, but alternative algorithms can offer additional perspectives and approaches to AP localization. OBJECTIVE: This study introduces and evaluates the diagnostic accuracy of the EPM algorithm in AP localization, comparing it with established algorithms Arruda and EASY. METHODS: A retrospective analysis was conducted on 138 patients from Hospital São Paulo who underwent catheter ablation. Three blinded examiners assessed the EPM algorithm's diagnostic accuracy against the Arruda and EASY algorithms. The gold standard for comparison was the radioscopic position of the AP where radiofrequency ablation led to pre-excitation disappearance on the ECG. RESULTS: EPM showed a diagnostic accuracy of 51.45%, closely aligning with Arruda (53.29%) and EASY (44.69%). Adjacency accuracy for EPM was 70.67%, with Arruda at 66.18% and EASY at 72.22%. Sensitivity for EPM in distinguishing left vs. right APs was 95.73%, with a specificity of 74.33%. For identifying septal vs. lateral right APs, EPM sensitivity was 82.79% with a specificity of 46.15%. These measures were comparable to those of Arruda and EASY. Inter-observer variability was excellent for EPM, with Kappa statistics over 0.9. CONCLUSION: The EPM algorithm emerges as a reliable tool for AP localization, offering a systematic approach beneficial for therapeutic decision-making in electrophysiology. Its comparable diagnostic accuracy and excellent inter-observer variability underscore its potential clinical applicability. Future research may further validate its efficacy in a broader clinical setting.

2.
J. eletrocardiol ; 84: 1-8, fev.2024. graf
Artigo em Inglês | CONASS, Sec. Est. Saúde SP, SESSP-IDPCPROD, Sec. Est. Saúde SP | ID: biblio-1532550

RESUMO

BACKGROUND: Accurate estimation of accessory pathway (AP) localization in patients with ventricular pre-excitation or Wolff-Parkinson-White (WPW) syndrome remains a diagnostic challenge. Existing algorithms have contributed significantly to this area, but alternative algorithms can offer additional perspectives and approaches to AP localization. OBJECTIVE: This study introduces and evaluates the diagnostic accuracy of the EPM algorithm in AP localization, comparing it with established algorithms Arruda and EASY. METHODS: A retrospective analysis was conducted on 138 patients from Hospital São Paulo who underwent catheter ablation. Three blinded examiners assessed the EPM algorithm's diagnostic accuracy against the Arruda and EASY algorithms. The gold standard for comparison was the radioscopic position of the AP where radiofrequency ablation led to pre-excitation disappearance on the ECG. RESULTS: EPM showed a diagnostic accuracy of 51.45%, closely aligning with Arruda (53.29%) and EASY (44.69%). Adjacency accuracy for EPM was 70.67%, with Arruda at 66.18% and EASY at 72.22%. Sensitivity for EPM in distinguishing left vs. right APs was 95.73%, with a specificity of 74.33%. For identifying septal vs. lateral right APs, EPM sensitivity was 82.79% with a specificity of 46.15%. These measures were comparable to those of Arruda and EASY. Inter-observer variability was excellent for EPM, with Kappa statistics over 0.9. CONCLUSION: The EPM algorithm emerges as a reliable tool for AP localization, offering a systematic approach beneficial for therapeutic decision-making in electrophysiology. Its comparable diagnostic accuracy and excellent inter-observer variability underscore its potential clinical applicability. Future research may further validate its efficacy in a broader clinical setting.


Assuntos
Síndrome de Wolff-Parkinson-White , Eletrofisiologia , Algoritmos , Eletrocardiografia , Feixe Acessório Atrioventricular
5.
Indian Pacing Electrophysiol J ; 19(5): 195-196, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31419491

RESUMO

We report a challenging case of a duodecapolar mapping catheter entrapment in Chiari network and its release by radiofrequency energy application with an ablation catheter.

6.
RELAMPA, Rev. Lat.-Am. Marcapasso Arritm ; 29(3): f:120-l:122, jul.-set. 2016. ilus
Artigo em Português | LILACS, Sec. Est. Saúde SP, SESSP-IDPCPROD, Sec. Est. Saúde SP | ID: biblio-831510

RESUMO

A cardiomiopatia hipertrófica é uma doença genética com apresentação, prognóstico e estratégias de tratamento variáveis. A visibilidade ligada à cardiomiopatia hipertrófica refere-se em grande parte a seu reconhecimento como causa comum de taquiarritmias e morte súbita cardíaca. O cardiodesfibrilador implantável é aceito como tratamento definitivo para prevenção de morte súbita, especialmente em pacientes de alto risco. Apesar da baixa prevalência, a via acessória é encontrada em 5% dos pacientes com cardiomiopatia hipertrófica e a ablação é o método de escolha, em decorrência do risco de taquiarritmias atriais. Relatamos o caso de um paciente com cardiomiopatia hipertrófica, em fase dilatada, com via acessória.


Hypertrophic cardiomyopathy is a genetic disease with variable presentation, prognosis and treatment strategies. The visibility linked to hypertrophic cardiomyopathy to a large extent refers to its recognition as a common cause of tachyarrhythmias and sudden cardiac death. Implantable cardiac defibrillator is accepted as definitive treatment for the prevention of sudden death, especially in high-risk patients. Despite the low prevalence, the accessory pathway is found in 5% of patients with hypertrophic cardiomyopathy and ablation is the method of choice due to risk of atrial tachyarrhythmias. We report the case of a patient with dilated hypertrophic cardiomyopathy and an accessory pathway.


Assuntos
Humanos , Masculino , Adulto , Síndrome de Wolff-Parkinson-White , Cardiomiopatia Hipertrófica/diagnóstico , Cardiomiopatia Hipertrófica/terapia , Cardiomiopatia Dilatada/diagnóstico , Cardiomiopatia Dilatada/terapia , Volume Sistólico , Morte Súbita Cardíaca , Desfibriladores Implantáveis/tendências , Ablação por Cateter/métodos
7.
São Paulo; IDPC; 2015. 58 p. ilus.
Monografia em Português | Sec. Est. Saúde SP, SESSP-IDPCPROD, Sec. Est. Saúde SP | ID: biblio-1083365

RESUMO

A amiloidose cardíaca é uma doença caracterizada pelo depósito de proteínas amiloides no tecido cardíaco. É uma doença subdiagnosticada ou diagnosticada já em fases muito avançadas, já que os métodos usualmente utilizados como o eletrocardiograma e o ecocardiograma transtorácico apresentam baixa sensibilidade nas fases iniciais da doença. O padrão ouro no diagnóstico dessa patologia é a biópsia endomiocárdica (BEM)...


Assuntos
Amiloidose , Imageamento por Ressonância Magnética , Insuficiência Cardíaca
8.
Rev. bras. ecocardiogr. imagem cardiovasc ; 26(1): 56-60, jan.-mar.2013. ilus
Artigo em Português | LILACS | ID: lil-663443

RESUMO

Miocárdio não compactado isolado é uma rara desordem da morfogênese endomiocárdica e que resulta em trabeculações múltiplas no ventrículo esquerdo. Relatamos um caso de paciente masculino, 32 anos, com quadro de dispneia e palpitações. O diagnóstico foi obtido pelo ecocardiograma transtorácico e confirmado pela ressonância magnética.


Isolated non-compaction of myocardium is a rare disorder of endomyocardial morphogenesis that results in multiple trabeculations in the left ventricle. We report the case of a male patient, 32 years, with dyspnea and palpitations; the diagnosis was obtained by transthoracic echocardiography and confirmed by MRI.


Assuntos
Humanos , Masculino , Adulto , Cardiopatias Congênitas/complicações , Ecocardiografia/métodos , Miocárdio Ventricular não Compactado Isolado , Insuficiência Cardíaca/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...